Organic synthesis and antisense effects of oligonucleotide-peptide conjugates

Current Organic Chemistry

Volumn 13, Issue 14, 2009, Pages 1366-1377

  Murao, Satoshi ^a   Fujii, Masayuki ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CYTOLOGY; PEPTIDES; RNA;

ANTISENSE; ANTISENSE OLIGONUCLEOTIDES; BIOLOGICAL EVALUATION; BIOLOGICAL PROPERTIES; DNA-PEPTIDE CONJUGATES; NUCLEAR EXPORT SIGNALS; NUCLEAR LOCALIZING SIGNALS; ORGANIC SYNTHESIS; PHARMACOLOGICAL PROPERTIES; SOLID PHASE FRAGMENT CONDENSATIONS;

OLIGONUCLEOTIDES;

EID: 73049104202     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527209789055072     Document Type: Article

References (47)

1. (a) Crooke, S.T. Progress in antisense technology. Annu. Rev. Med., 2004, 55, 61-95.
2. (b) Crooke, S.T. An overview of progress in antisense therapeutics. Antisense Nucleic Acid Drug Dev., 1998, 8, 115-122.
3. (c) Agrawal, S. Antisense oligonucleotides: towards clinical trials. Trends Biotech., 1996, 14, 376-387.
4. (d) Milligan, J. F.; Matteucci, J. C.; Martin, M. D. Current concepts in antisense drug design. J. Med. Chem., 1993, 36, 1923-1937.
5. (a) Tung, C.-H. Preparation and applications of peptide-pligonucleotide conjugates. Bioconjug. Chem., 2000, 11, 605-618.
6. (b) Fischer, P. M.; Krausz, E.; Lane, D. P. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjug. Chem., 2001, 12, 825-841.
7. (c) Eisele, F.; Owen, D. J.; Waldmann, H.; Peptide conjugates as tools for the study of biological signal transduction. Bioorg. Med. Chem., 1999, 7, 193-234.
8. (d) Zubin, E. M.; Romanova, E. A.; Oretskaya, T. S. Modern methods for the synthesis of peptide-oligonucleotide conjugates. Russ. Chem. Rev., 2002, 71, 239-264.
9. (a) Tung, C.-H.; Wang, J.; Leibowitz, M. J.; Stein, S. Dual-Specificity Interaction of HIV-1 TAR RNA with Tat peptideoligonucleotide conjugates. Bioconjug. Chem., 1995, 6, 292-295.
10. (b) Antopolsky, M.; Azhayeva, E.; Tengvall, U.; Auriola, S.; Jaaskelainen, I.; Ronkko, S.; Honkakoski, P.; Urtti, A.; Lonnberg, H.; Azhayev, A. Peptide-Oligonucleotide Phosphorothioate Conjugates with Membrane Translocation and Nuclear Localization Properties. Bioconjug. Chem., 1999, 10, 598-606.
11. Stetsenko, D. A.; Gait, M. J. Efficient conjugation of peptides to oligonucleotides by "native ligation" J. Org. Chem., 2000, 65, 4900-4908.
12. (a) Soukchareun, S.; Tregear, G.W.; Haralambidis, J. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides. Bioconjug. Chem., 1995, 6, 43-53.
13. (b) Haralambidis, J.; Duncan, L.; Tregear, G.W. The solid phase synthesis of oligonucleotides containing a 3'-peptide moiety. Tetrahedron Lett., 1987, 28, 5199-5202.
14. (a) Antopolsky, M.; Azhayeva, E.; Tengvall, U.; Azhayev, A. Towards a general method for the stepwise solid-phase synthesis of peptide-oligonucleotide conjugates. Tetrahedron Lett., 2002, 43, 527-530.
15. (b) Antopolssky, M.; Azhayev, A. Stepwise solid-phase synthesis of peptide-oligonucleotide phosphorothioate conjugates employing Fmoc peptide chemistry. Tetrahedron Lett., 2000, 41, 9113-9117.
16. (c) Antopolssky, M.; Azhayev, A. Stepwise solid-phase synthesis of peptide-oligonucleotide conjugates on new solid supports. Helv. Chim. Acta., 1999, 82, 2130-2140.
17. Stetsenko, D. A.; Gait, M. J. Total Stepwise solid-phase synthesis of oligonucleotide-(3'→N)-peptide conjugates. Org. Lett., 2002, 4, 3259-3262.
18. (a) Peyrottes, S.; Mestre, B.; Burlina, F.; Gait, M. J. The synthesis of peptide-oligonucleotide conjugates by a fragment coupling approach. Tetrahedron, 1998, 54, 12513-12522.
19. (b) Zubin, E. M.; Romanova, E. A.; Volkov, E. M.; Tashlitsky, V. N.; Korshunova, G. A.; Shabarova, Z. A.; Oretskaya, T. S. Oligonucleotide-peptide conjugates as potential antisense agents. FEBS Lett., 1999, 456, 59-62.
20. (c) Tetzlaff, C. N.; Schwope, I.; Bleczinski, C. F.; Steinberg, J. A.; Richert, C. A convenient synthesis of 5'-amino-5'-deoxythymidine and preparation of peptide-DNA hybrids. Tetrahedron Lett., 1998, 39, 4215-4218.
21. (d) Bologna, J.-C.; Tosquellas, G.; Morvan, F.; Rayner, B.; Imbach, J.-L. The Prooligonucleotide Approach: Synthesis of mixed SATE-phosphotriester phosphodiester oligonucleotides. Nucleosies Nucleotides, 1999, 18, 1433-1434.
22. (a) Kubo, T.; Morikawa, M.; Ohba, H.; Fujii, M. Synthesis of DNA-peptide conjugates by solid phase fragment condensation Org. Lett., 2003, 5, 2623-2626.
23. (b) Kubo, T.; Dubey, K.; Fujii, M. A novel solid phase synthesis of DNA conjugates. Nucleosides Nucleotides Nucleic Acids, 2001, 20, 1321-1324.
24. Dingwell, C.; Laskey, R. A. Protein import into the cell nucleus. Annu. Rev. Cell Biol., 1986, 2, 367-390
25. GoldFarb, D. S.; Gariepy, J.; Schoolnik, G.; Kornberg, R. D. Synthetic peptides as nuclear localization signals. Nature, 1986, 322, 641-642.
26. Newmeyer, D. D.; Lucocq, J. M.; Buerglin, T. R.; DeRobertis, E. M. Assembly in vitro of nuclei active in nuclear protein transport: ATP is required for nucleoplasmin accumulation. EMBO J., 1986, 5, 501-510.
27. Fujii, M.; Yokoyama, K.; Kubo, T.; Ueki, R.; Abe, S.; Goto, K.; Niidome, T.; Aoyagi, H.; Iwakuma, K.; Ando, S.; Ono, S. Design, synthesis and characterization of DNA binding peptides. Pept. Sci., 2001, 2000, 109-112.
28. Kubo, T.; Fujii, M. Specific binding and stabilization of DNA and phosphorothioate DNA by amphiphilic α-helical peptides. Nucleosides Nucleotides Nucleic Acids, 2001, 20, 1313-1316.
29. Kubo, T.; Yokoyama, K.; Sasaki, K.; Dubey, K. K.; Fujii, M. Synthesis and biological properties of DNA-peptide conjugates. Nucleic Acids Res. Suppl., 2001, 1, 75-76.
30. (b) Yokoyama, K.; Kubo, T.; Fujii, M. Synthesis and biological activity of DNA-NLS peptide conjugate. Pept. Sci., 2001, 2002, 313-316.
31. (a) Yano, M.; Kubo, T.; Yokoyama, K.; Ueki, R.; Sasaki, K.; Anno, Y.; Ohba, H.; Fujii, M. Control of intracellular delivery of oligonucleotides by conjugation with signal peptides. Nucleosides Nucleotides Nucleic Acids, 2003, 22, 1367-1369.
32. (b) Kubo, T.; Ueki, R.; Anno, Y.; Yano, M.; Sasaki, K.; Ohba, H.; Fujii, M. Properties of conjugate DNA enzymes. Nucleosides Nucleotides Nucleic Acids, 2003, 22, 1491-1493.
33. (a) Kim, N. W.; Piatyszek, M. A.; Prowse, K. R.; Harley, C. B.; West, M. D.; Ho, P. L. C.; Coviello, G. M.; Wright, W. E.; Weinrich, S. L.; Shay, J. W. Science, 1994, 266, 2011-2015.
34. (b) Goerlich, D.; Kutay, U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell. Dev. Biol., 1999, 15, 607-660.
35. Chaloin, L.; Vidal, P.; Lory, P.; Mery, J.; Lautredou, N.; Divita, G.; Heitz, F. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties. Biochem. Biophys. Res. Commun., 1998, 243, 601-608.
36. Zanta, M. A.; Belguise-Valladier, P.; Behr, J.-P. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA, 1999, 96, 91-96.
37. (a) Kubo, T.; Rumiana, b.; Ohba, H.; Fujii, M. Antisense effects of DNA-peptide conjugates. Nucleic Acids Res. Suppl., 2003, 3, 179-180.
38. (b) Kubo, T.; Anno, Y.; Yano, M.; Takamori, K.; Rumiana, B.; Ohba, H.; Fujii, M. Control of intracellular delivery and inhibition of genetic expression by DNA-peptide conjugates. Nucleic Acids Res. Suppl., 2003, 3, 237-238.
39. (c) Kubo, T.; Takamori, K.; Kanno, K.; Rumiana, B.; Ohba, H.; Matsukisono, M.; Akebiyama, Y.; Fujii, M. RNA cleavage efficiency, enhanced cellular uptake and controlled intracellular localization of conjugate DNAzymes. Bioorg. Med. Chem. Lett., 2005, 15, 167-170.
40. (a) Bachmann, A. S.; Surovoy, A.; Jung G.; Moelling, K. Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides. J. Mol. Med., 1998, 76, 126-132.
41. (b) Astriab-Fisher, A.; Sergueev, D. S.; Fisher, M.; Ramsay B.; Juliano, R. L. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem. Pharm., 2000, 60, 83-90.
42. (c) Antopolsky, M.; Azhayeva, E.; Tengvall, U.; Auriola, S.; Jaaskelainen, I.; Ronkko, S. S.; Honkakoski, P.; Urtti, A.; Lonnberg, H.; Azhayev, A. Peptide-Oligonucleotide Phosphorothioate Conjugates with Membrane Translocation and Nuclear Localization Properties. Bioconjug. Chem., 1999, 10, 598-606.
43. (d) Chen, C.-P.; Li, X.-X.; Zhang, L.-R.; Min, J.-M.; Chan, J. Y.-W.; Fung, K.-P.; Wang, S.-Q.; Zhang, L.-H. Synthesis of Antisense Oligonucleotide-Peptide Conjugate Targeting to GLUT-1 in HepG-2 and MCF-7 Cells. Bioconjug. Chem., 2002, 13, 525-529.
44. (e) Benimetskaya, L.; Guzzo-Pernell, N.; Liu, S.-T.; Lai, J. C. H.; Miller, P.; Stein, C. A. Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells. Bioconjug. Chem., 2002, 13, 177-187.
45. (a) Kuwabara, T.; Warashima, M.; Nakayama, A.; Ohkawa, J.; Taira, K. tRNAVal-heterodimeric maxizymes with high potential as gene-inactivating agents: Simultaneous cleavage at two sites in HIV-1 tat mRNA in cultures cells. Proc. Natl. Acad. Sci., USA, 1999, 96, 1886-1891.
46. (b) Warashima, M.; Kuwabara, T.; Kato, Y.; Sano, M.; Taira, K. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA. Proc. Natl. Acad. Sci., USA, 2001, 98, 5572-5577.
47. 2+-calmodulin, participates in regulation of telomerase activity in Burkitt's lymphoma cells. Cancer Chemother. Pharmacol., 2004, 54, 161-172.